Subgroup analysis suggested that participants who have diabetes, hypertension, coronary heart disease and lower ALT levels (<17.00 U/L), AST levels and HbA1c levels (<5.5%) were associated with a decreased risk of mortality (all p < 0.05). This evidence concerns the gene GPT and coronary artery disorder.